Impact Biomedical Stock Set to Reverse Split on Wednesday, September 23rd (NYSEAMERICAN:IBO)

Impact Biomedical Inc. (NYSEAMERICAN:IBO)’s stock is going to reverse split on Wednesday, September 23rd. The 1-12.62 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Tuesday, September 22nd.

Impact Biomedical Price Performance

Shares of NYSEAMERICAN IBO opened at $0.48 on Tuesday. The business has a fifty day moving average of $0.46 and a two-hundred day moving average of $0.52. Impact Biomedical has a 52-week low of $0.37 and a 52-week high of $0.83.

Impact Biomedical Company Profile

Impact Biomedical, Inc (“IBIO”) currently is a holding company operating mainly through our majority owned subsidiary, Global BioLife, Inc, which was incorporated on April 14, 2017. The Company is committed to both funding research and developing intellectual property portfolio. We currently focus on research in three main areas: (i) development of a universal therapeutic drug platform; (ii) a new sugar substitute; and (iii) a multi-use fragrance. IBIO discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.